FIELD: medicine.
SUBSTANCE” invention relates to medicine, namely ophthalmology. A map of the chorioicapillary layer with the measured area of type I choroidal neovascularization (CNV) is preliminarily obtained, which is superimposed on the map of the superficial vascular plexus and the contour of CNV is outlined by the location of the vessels of the superficial vascular plexus. Then, in the micro-pulse mode, the parameters of the sub-threshold micro-pulse laser exposure (STMPLE) are tested: the spot diameter is 100 microns, the borehole is 4.7%, the pulse exposure is 50 microseconds, the pulse packet duration is 200 ms. The selected power parameters are reduced by 50%. Next, STMPLE is initially carried out along the border of CNV and the detachment of the SNR: the applicates are applied one after another along the border of CNV with the position of each application on of its area on the zone of CNV and of the area on the zone of detachment of the sensorineural retina (SNR). In this case, the applications are applied, starting from the upper part of type I HCV, from left to right to the opposite border of the HCV. Then the impact is carried out in the opposite direction to the right border of HCV with the overlap of each subsequent application on of the area. After that, STMPLE is carried out over the entire area of the type I CNV, while each application is applied with overlap on of the area of the previous application. Next, STMPLE is carried out in the projection area of the detachment of the SNR over the entire area with the setting of the applicates “joint to joint”. An angiogenesis inhibitor is administered intravitreally on the next day after STMPLE.
EFFECT: method provides for more pronounced fibrosis of type I CNV, reducing the risk of recurrence or progression of choroidal neovascularization.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CHOOSING TACTICS FOR THE TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY COMPLICATED BY TYPE 1 CHOROIDAL NEOVASCULARIZATION | 2022 |
|
RU2788279C1 |
METHOD OF CENTRAL SEROUS CHORIORETINOPATHY TREATMENT | 2022 |
|
RU2797276C1 |
METHOD OF DIFFERENTIATED APPROACH TO SURGICAL TREATMENT OF CHRONIC FORM OF CENTRAL SEROUS CHORIORETINOPATHY | 2024 |
|
RU2823160C1 |
METHOD OF TREATMENT OF CHOROIDAL NEOVASCULATION | 2018 |
|
RU2676075C1 |
COMBINED METHOD FOR TREATING CHOROIDAL NEOVASCULATION OF ALL TYPES | 2021 |
|
RU2770745C1 |
METHOD OF TREATING NEUROSENSORY RETINAL DETACHMENT USING NAVIGATION PANRETINAL SUBTHRESHOLD MICROPULSE LASER EXPOSURE IN CASES OF INCOMPLETE RETINAL ADHESION AFTER SURGICAL TREATMENT OF RHEGMATOGENOUS RETINAL DETACHMENT | 2023 |
|
RU2821277C1 |
METHOD OF INDIVIDUAL SELECTION OF ENERGY PARAMETERS OF MICROPULSE MODE ON NAVILAS 577S LASER FOR TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY | 2018 |
|
RU2669858C1 |
METHOD FOR CENTRAL SEROUS CHORIORETINOPATHY THERAPY | 2016 |
|
RU2629804C1 |
METHOD FOR COMPREHENSIVE TREATMENT OF MACULAR EDEMA ASSOCIATED WITH OCCLUSION OF BRANCH OF CENTRAL RETINAL VEIN WITH OCT CONTROL IN REAL TIME | 2019 |
|
RU2749122C1 |
METHOD OF TREATMENT OF MACULAR FOR AGE-RELATED MACULAR DEGENERATION | 2017 |
|
RU2647142C1 |
Authors
Dates
2021-12-22—Published
2021-03-11—Filed